Postmarketing surveillance of new antiepileptic drugs: The tribulations of trials

Epilepsia

Volumn 43, Issue 9, 2002, Pages 951-955

  French, Jacqueline A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; ETIRACETAM; FELBAMATE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ANHIDROSIS; ANTICONVULSANT THERAPY; APLASTIC ANEMIA; CLINICAL RESEARCH; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EPILEPSY; HUMAN; LIVER FAILURE; NOTE; PANCREATITIS; PRIORITY JOURNAL; VISUAL FIELD DEFECT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTICONVULSANTS; CLINICAL TRIALS; DRUG APPROVAL; EPILEPSY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 0036714358     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2002.24302.x     Document Type: Note

References (24)

1. Valproate-associated pancreatitis
2. Valproic acid hepatic fatalities: A retrospective review
3. Valproic acid hepatic fatalities, II: US experience since 1984
4. Severe persistent visual field constriction associated with vigabatrin
5. Evaluation of case reports of aplastic anemia among patients treated with felbamate
6. Pancreatitis during sodium valproate treatment
7. Hypohidrosis related to the administration of topiramate to children
8. Changes in body weight with chronic, high-dose gabapentin therapy
9. Weight gain during treatment with valproate
10. Weight gain and gabapentin therapy
11. Heat stroke-like episode in a child caused by zonisamide
12. Principles of signal detection in pharmacovigilance
13. Efficacy of gabapentin as adjunctive therapy in a large, multicenter study: The Steps Study Group
14. Vigabatrin-associated retinal cone system dysfunction: Electroretinogram and ophthalmologic findings
15. Postmarketing surveillance of adverse drug reactions in general practice, II: Prescription-event monitoring at the University of Southampton
16. Spontaneous adverse drug reaction reporting vs event monitoring: A comparison
17. Adverse event monitoring in lamotrigine patients: A pharmacoepidemiologic study in the United Kingdom
18. Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy
19. Lamotrigine as an add-on drug in typical absence seizures
20. Topiramate in the treatment of severe myoclonic epilepsy in infancy
21. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy
22. Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy
23. Double-blind, placebo-controlled evaluation of cinromide in patients with the Lennox-Gastaut Syndrome
24. Causation and disease: The Henle-Koch postulates revisited